The clinical characteristics of the groups for the periods 1 January 2017–31 December 2019 and 1 January 2020–21 June 2020
| Measure | Period | |
| 1 January 2017–31 December 2019 | 1 January 2020–21 June 2020 | |
| Unique persons | 747 241 | 187 769 |
| Total visits | 2 910 519 | 403 906 |
| Median age (10th, 90th percentiles)* | 41 (14, 64) | 40 (19, 62) |
| Gender, men | 341 798 (45.7%) | 80 240 (42.7%) |
| Gender, women | 405 442 (54.3%) | 107 528 (57.3%) |
| Acute upper respiratory tract infection URTI (J06; N, % of total patients) | 425 202 (56.9) | 92 148 (49.1) |
| Influenza (J10; N, % of total patients) | 4 353 (0.6) | 741 (0.4) |
| COVID-19 Tests (N, % of total patients) | 0 (0) | 21 523 (11.5) |
| Confirmed COVID-19 infection (N, % of suspected COVID-19 cases) | 0 (0) | 540 (2.5) |
| Urinary tract infection UTI (N, % of total patients) | 15 902 (2.1) | 2 801 (1.5) |
| Prescription of antibiotics (N, % of total patients) | 558 823 (74.8) | 96 133 (51.2) |
The most notable differences in the periods are the inclusion of COVID-19 patients for the latter period, whose testing began in May 2020, and the smaller proportion of prescriptions for antibiotics for the latter period compared with the earlier.
*Calculated from total visits at the time of the event.
URTI, upper respiratory tract infection.